Background: Nosocomial pneumonia (NP), hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia
(VAP), is an important cause of morbidity and mortality in hospitalized patients. One of the factors contributing to a high
mortality rate of HAP and VAP could be antibiotic resistance among the causative agents.
Objective: To determine prevalence of bacterial pathogens clinical features, risk factors of HAP and VAP, antimicrobial
resistance among major respiratory pathogens, clinical implication of antimicrobial resistance, antimicrobial regimens used,
and treatment outcomes of adult patients with HAP and VAP at Siriraj Hospital.
Material and Method: This was a prospective, hospital-based, active surveillance study on HAP and VAP in hospitalized
adults at Siriraj Hospital from December 2007 to March 2009. The patients with HAP and VAP were followed prospectively
until they expired or were discharged from the hospital.
Background: Nosocomial pneumonia (NP), hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia(VAP), is an important cause of morbidity and mortality in hospitalized patients. One of the factors contributing to a highmortality rate of HAP and VAP could be antibiotic resistance among the causative agents.Objective: To determine prevalence of bacterial pathogens clinical features, risk factors of HAP and VAP, antimicrobialresistance among major respiratory pathogens, clinical implication of antimicrobial resistance, antimicrobial regimens used,and treatment outcomes of adult patients with HAP and VAP at Siriraj Hospital.Material and Method: This was a prospective, hospital-based, active surveillance study on HAP and VAP in hospitalizedadults at Siriraj Hospital from December 2007 to March 2009. The patients with HAP and VAP were followed prospectivelyuntil they expired or were discharged from the hospital.
การแปล กรุณารอสักครู่..